- For US Healthcare Providers
- Full Prescribing Information
REQUEST INFORMATION
ACCESS AND AFFORDABILITY
FIRST-LINE BIOLOGIC ACCESS* IS AVAILABLE NATIONWIDE FOR
100%
OF MEDICARE
PART B PATIENTS1
83%
OF COMMERCIAL PATIENTS
WITHOUT A BIOLOGIC
STEP-EDIT1†‡
ELIGIBLE COMMERCIALLY INSURED PATIENTS
PAY JUST $5 PER INFUSION
with maximum annual benefit of $20,000§
Find out about major insurers that provide coverage in your state.
*First-line biologic: Brand-name drug that does not require trial on another biologic product prior to utilization.
†Based on an analysis of major insurers that includes approximately 90% of commercially insured patients.
‡No biologic-step edit. Brand-name drug that does not require trial on another product prior to utilization.
§The Janssen CarePath rebate expires after $20,000 maximum annual benefit or 12 months from first eligible date of service, whichever comes first. Program is not available to individuals enrolled in federal or state subsidized healthcare programs that cover prescription drugs, including Medicare, such as the Medicare Part D prescription drug benefit; Medicaid; TRICARE®; or any other federal or state healthcare plan, including pharmaceutical assistance programs.
Providing access, affordability, and treatment support to help your patients start and stay on Janssen medications as prescribed
Helping to verify
insurance coverage
and assisting with
the prior authorization
and appeals processes
Identifying
affordability options
that may be available
for your patients
Providing
reimbursement
information
Providing care
coordination and
patient support resources
Call us. We’re here to help.
877-CarePath
(877-227-3728)
||The Janssen CarePath rebate expires after $20,000 maximum annual benefit or 12 months from first eligible date of service, whichever comes first. Program is not available to individuals enrolled in federal or state subsidized healthcare programs that cover prescription drugs, including Medicare, such as the Medicare Part D prescription drug benefit; Medicaid; TRICARE®; or any other federal or state healthcare plan, including pharmaceutical assistance programs.